Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Cytokinetics, Incorporated (CYTK) had Receiveable Turnover of 5.87 for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$7.53M |
|
$-526.24M |
|
-- |
|
$7.53M |
|
$503.74M |
|
$-496.20M |
|
$-30.04M |
|
$-526.24M |
|
$-526.24M |
|
$-526.24M |
|
$-526.24M |
|
$-526.24M |
|
$-526.24M |
|
$-496.20M |
|
$-484.31M |
|
96.52M |
|
96.52M |
|
$-5.45 |
|
$-5.45 |
|
| Balance Sheet Financials | |
$628.05M |
|
$68.75M |
|
$196.26M |
|
$824.32M |
|
$102.68M |
|
$607.37M |
|
$1.11B |
|
$1.21B |
|
$-386.32M |
|
$-386.32M |
|
$-386.32M |
|
101.64M |
|
| Cash Flow Statement Financials | |
$-414.33M |
|
$239.25M |
|
$221.32M |
|
$67.18M |
|
$113.40M |
|
$46.22M |
|
$72.06M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.12 |
|
-- |
|
-- |
|
2.75 |
|
-1.60 |
|
100.00% |
|
-6589.71% |
|
-6589.71% |
|
-6431.78% |
|
-6988.63% |
|
-6988.63% |
|
$-415.75M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
|
Receiveable Turnover |
5.87 |
62.19 |
|
136.22% |
|
136.22% |
|
-63.84% |
|
-238.07% |
|
$-3.80 |
|
$-4.31 |
|
$-4.29 |
|